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RepeatabilityCerebrovascular reactivity (CVR) can be mapped using BOLD fMRI to provide a clinical insight into vascular health
that can be used to diagnose cerebrovascular disease. Breath-holds are a readily accessible method for producing
the required arterial CO2 increases but their implementation into clinical studies is limited by concerns that patients
will demonstrate highly variable performance of breath-hold challenges. This study assesses the repeatability of CVR
measurements despite poor task performance, to determine if and how robust results could be achieved with
breath-holds in patients. Twelve healthy volunteers were scanned at 3T. Six functional scans were acquired, each
consisting of 6 breath-hold challenges (10, 15, or 20 s duration) interleaved with periods of paced breathing.
These scans simulated the varying breath-hold consistency and ability levels thatmay occur in patient data. Uniform
ramps, time-scaled ramps, and end-tidal CO2 data were used as regressors in a general linear model in order to
measure CVR at the greymatter, regional, and voxelwise level. The intraclass correlation coefﬁcient (ICC) quantiﬁed
the repeatability of the CVR measurement for each breath-hold regressor type and scale of interest across the
variable task performances. The ramp regressors did not fully account for variability in breath-hold performance
and did not achieve acceptable repeatability (ICC b 0.4) in several regions analysed. In contrast, the end-tidal CO2
regressors resulted in “excellent” repeatability (ICC = 0.82) in the average greymatter data, and resulted in accept-
able repeatability in all smaller regions tested (ICC N 0.4). Further analysis of intra-subject CVR variability across the
brain (ICCspatial and voxelwise correlation) supported the use of end-tidal CO2 data to extract robust whole-brain
CVR maps, despite variability in breath-hold performance. We conclude that the incorporation of end-tidal CO2
monitoring into scanning enables robust, repeatable measurement of CVR that makes breath-hold challenges
suitable for routine clinical practice.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Cerebral blood vessels are constantly constricting and dilating to reg-
ulate and stabilise the supply of blood to downstream brain tissue. When
functioning properly, these mechanisms protect against ﬂuctuations in
blood pressure (i.e., cerebral autoregulation) and support increases in
metabolism associated with neural activation. However, when these
vascular mechanisms are disrupted, such as in the presence of arterial
plaques or vessel hardening, the downstream tissue may be at risk.
Cerebrovascular reactivity (CVR) is the response of cerebral blood ves-
sels to vasoactive stimuli such as exogenous drugs (e.g., acetazolamide) or
arterial CO2 levels. The potent vasodilatory nature of arterial CO2 in
humans, described by Kety and Schmidt (1948), can be manipulated
using inhalation of air with increased CO2 content to induce hypercapnia.erms of the Creative Commons
tribution, and reproduction in
re credited.
ogy, Cardiff University, Cardiff,
).
blished by Elsevier Inc. All rights reVoluntary respiratory challenges (e.g., breath-holding or deep breathing)
can also causemore transient changes (Bright et al., 2010). CVRmeasure-
ments can assist in the diagnosis of cerebrovascular disease and aid treat-
ment planning in these patients. For example, a recent meta-analysis of
the CVR literature revealed strong association between CVR impairment
and the risk of ischaemic event in stenosis patients (Gupta et al., 2012).
Blood Oxygenation Level Dependent (BOLD) contrast functional
magnetic resonance imaging (fMRI) takes advantage of the differing
magnetic properties of oxygenated and deoxygenated haemoglobin to
noninvasively measure changes in local vascular properties (Bandettini
et al., 1992; Kwong et al., 1992; Ogawa et al., 1992). Combining this im-
aging modality with vasoactive stimuli, such as manipulations of arterial
gas content, is a robust means for characterising CVR throughout the
brain (Shiino et al., 2003). Currently, clinical CVR studies involving ele-
vated CO2 levels are typically achieved using gas administration during
scanning (Heyn et al., 2010), but this may not be appropriate or feasible
for all research and patient scenarios.
Breath-holds offer a simple alternative method for elevating arterial
CO2 levels, and the BOLD CVR measurements achieved using these re-
spiratory challenges are similar to those obtained using inhaled CO2
methods (Kastrup et al., 2001). The relative simplicity of a breath-holdserved.
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comfortable presence of a face mask within the head coil, and by being
self-directed it allows the patient to abort the task at any point, improving
real-time safety and reassurance for the patient. Several other clinical
areas such as cardiac imaging (Mahnken et al., 2007) already incorporate
breath-holds, demonstrating that it is a well-tolerated technique.
However, the speciﬁcs of breath-hold execution determine the
magnitude and dynamics of the BOLD signal response, and may impact
how CVR is quantiﬁed. Firstly, the issue of breath-hold duration is po-
tentially critical: although even short breath-holds (3 s) can cause a
measurable BOLD response, the number of voxels exhibiting signiﬁcant
BOLD signal changes is increased with the duration of the breath-hold
(Abbott et al., 2005). Longer breath-holds also offermore robust and re-
peatable BOLD responses across scanning sessions spanning weeks
(Magon et al., 2009). Thus, although a 20-second breath-hold may be
desirable to achieve a repeatable, robust BOLD response, this challenge
may be too difﬁcult for certain patient groups.
Several studies have established good practice guidelines for repeat-
able breath-hold fMRI experiments in healthy subjects. For example,
paced breathing between challenges provides amore consistent baseline
condition, from which the breath-hold signal response can be more
accurately extracted, exhibiting less inter-trial variability (Scouten and
Schwarzbauer, 2008). In addition, breath-holds after expiration may
offer better reproducibility: following normal exhalation, the lungs re-
turn to the state of “functional reserve capacity,” at which the lungs,
chest, and diaphragm are resting at equilibrium. This is a more re-
peatable starting point for breath-hold challenges, compared with
self-directed inspirations that do not involve a natural equilibrium posi-
tion (Scouten and Schwarzbauer, 2008). End-expiration breath-holds
also avoid the biphasic BOLD signal response that is observed in
end-inspiration challenges (Thomason and Glover, 2008).
However, most of these studies have not addressed the question
of whether breath-hold challenges are useful for studying CVR in clin-
ical patients. A recent publication examining the feasibility of map-
ping BOLD CVR in patients showed successful results in 364 of 434
patients using gas administration techniques; the authors speciﬁcally
state that while breath-holds may provide similar information, “un-
fortunately, the degree of cooperation for breath holding will vary
too much over the range of patients with neurologic diseases to be
considered routinely useful” (Spano et al., 2013). Indeed, it may be
more difﬁcult for patients to execute a breath-hold, even those con-
sidered “short” by research standards (e.g., 15 s). There is likely to
be reduced time to familiarise patients with the breath-hold tech-
nique prior to scanning when in a clinical environment. Breath-hold
performance may therefore be more variable, and less repeatable, in
patient studies.
In this study, we simulate patient behaviour in healthy volunteers.
This allows more ﬂexibility in our experiment duration and removes
the confounds of age-related or pathological brain changes in order
to isolate the effects of poor breath-hold performance on BOLD CVR
measurement. Based on previous ﬁndings in healthy volunteers
(Murphy et al., 2011), we hypothesise that using end-tidal gas mea-
surements will enable CVR to be mapped in a robust, repeatable man-
ner, across the brain, despite the underlying patient “misbehaviour.”
End-tidal CO2 values, which represent the averaging of alveolar values,
are linked to arterial CO2 levels; ﬂuctuations in end-tidal CO2 are
commonly used as a surrogate for ﬂuctuations in arterial CO2 (Robbins
et al., 1990). The change in arterial CO2 levels associated with the
breath-hold challenge is the direct cause of the vascular response (and
BOLD signal change), and thus measuring these CO2 effects should pro-
vide a full model of the hypercapnia stimulus regardless of how the
challenge was actually executed. Inter-subject differences in the physi-
ological response to the breath-hold challenge are also fully incorporat-
ed into the CO2 data collected. The results of this study allow us to offer
advice on how to achieve reproducible CVR measurements in patients
using BOLD fMRI and breath-hold challenges.Methods
Data acquisition
Twelve healthy subjects (aged 32 ± 6 years, 5 female)were scanned
using a 3T GE HDx scanner (Milwaukee, WI, USA) equipped with an
8-channel receive head coil. Functional data were acquired using
a BOLD-weighted gradient-echo echo-planar imaging sequence
(TR/TE = 2000/35 ms; FOV = 22.4 cm; 35 slices, slice thickness =
4 mm; resolution = 3.5 × 3.5 × 4.0 mm3). Six breath-hold scans and
one resting scan were collected in a randomised order, each
consisting of 165 volume acquisitions (5.5 min). A whole-brain high-
resolution T1-weighted structural image was acquired (resolution =
1 × 1 × 1 mm3), for the purposes of image registration. Cardiac pulsa-
tionswere recorded using a ﬁnger plethysmograph and respirationwas
measured via respiratory bellows. Expired gas content was continuous-
ly monitored via a nasal cannula, and O2 and CO2 data were recorded
(AEI Technologies, PA, USA). This study was approved by the Cardiff
University School of Psychology Ethics Committee, and all volunteers
gave written informed consent.
Breath-hold paradigms
The breath-hold paradigms were cued using textual instructions
viewed through a mirror positioned on the head coil. The challenge is
schematically presented in Fig. 1. In the periods between breath-hold
challenges, subjects followed paced breathing commands at a rate of
1/6 Hz. A countdown timer indicated the number of seconds remaining
before the next challenge. The breath-hold always followed an expira-
tory breath. A new countdown, beginning at either 10, 15 or 20 s, indi-
cated the time remaining in the challenge. Upon completion, the subject
was cued to “Breathe Out” to expel any remaining gas and provide an
accurate end-tidal CO2 measure, before having several seconds of
un-paced recovery breathing. Paced breathing was then resumed.
We considered two performance factors when simulating patient
breath-hold data: ability and consistency. Patient ability reﬂects a
physical limit during breath-holding: certain individuals or patient
groups may not be able to complete the target breath-hold length and
must abort the challenge prematurely. Patient consistency reﬂects the
potential for variable performance across multiple breath-hold trials.
All breath-hold scans consisted of 6 breath-hold challenges, cued in
the manner described above. In the All10, All15 and All20 breath-hold
runs, the length of the breath-hold was held constant throughout the
run at 10 s, 15 s and 20 s, respectively. In the Avg12.5, Avg15 and
Avg17.5 runs, a combination of the three breath-hold lengths was cho-
sen so that the average breath-hold length was 12.5 s, 15 s and 17.5 s,
respectively. These scans simulate different breath-hold consistency
levels at low, medium, and high ability levels.
The start times of the 6 breath-hold challenges were held constant
(equally spaced) in all of the 6 paradigms, and were always preceded
by 24 s of paced breathing. When breath-holds were shorter than 20 s,
the “recovery” period was extended from the original 6 s up to 11 s or
16 s as necessary.
Data analysis
A schematic of the analysis pipelines used in this study is presented
in Fig. 2.
Data preprocessing
The functional data were volume registered, motion corrected,
time-shifted to a common temporal origin, brain extracted, and converted
to percentage BOLD change (AFNI, http://afni.nimh.nih.gov/afni (Cox,
1996)). A grey matter (GM) segmentation map in functional image
space was calculated from the mean volume of the resting dataset using
a T1-mapping technique (Bodurka et al., 2007). All other regions of in-
terest were deﬁned using the MNI atlas (Mazziotta et al., 2001). The
Fig. 1. Schematic of the breath-hold paradigms. Each challenge was preceded by paced breathing (6 s period) ending on an exhalation, and at the end of the breath-hold a small
exhalation was made to provide accurate end-tidal measurements. Following free “recovery” breathing, the paced breathing was resumed. An example trace from the respiratory
bellows is provided.
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which was then normalised to the MNI152 standard brain (MNI152,
nonlinearly derived, McConnell Brain Imaging Centre, Montreal Neuro-
logical Institute, McGill University, Montreal, Quebec, Canada). This
transformation was inverted and applied to transform regions of inter-
est (ROIs) from standard space into the functional space of each subject.
These transformed regions were then masked by the subject-speciﬁc
GM mask.
Breath-hold model
Three regressor categories were used to analyse the %BOLD signal
change associated with the breath-hold challenges.
• All 20s Ramps— all breath-holds are modelled by a 20-second linear
ramp, convolved with an HRF.
• Time-scaled Ramps— the duration of each breath-hold is known (10,
15, or 20 s) and challenges are modelled by a ramp lasting the cor-
rect length with an amplitude proportional to the duration and con-
volved with an HRF.
• End-tidal CO2 — the PETCO2 data were extracted and convolved with
an HRF. These regressors were not normalised, but maintained in
absolute units of mm Hg.
The All 20s Ramps pipeline presumes that all breath-holds last
20 s. This model, which does not incorporate any respiratory moni-
toring in the analysis, does not take into account variation in patient
performance simulated in the six breath-hold scans. The BOLD breath-
hold response has been shown to increase linearly with time (Murphy
et al., 2011), and thus the challenges were modelled as linear ramps
lasting 20 s with a ﬁnal amplitude of 1. The Time-scaled Ramps pipeline
assumes that any variance in the duration of breath-hold is known
(i.e., from the respiratory bellows recordings), and challenges were
modelled as a constant linear slope over the “corrected” period of
time. Finally, the End-tidal CO2 pipeline makes no assumption about
breath-hold length, but instead models the challenge response with
the recorded end-tidal CO2 values. In this study, we hypothesise that
monitoring end-tidal CO2 is a more accurate representation of the
subject's physiological response to a breath-hold than the duration of
the breath-hold challenge, and thus a better ﬁt to the BOLD response.
Scale of interest
Although measuring CVR in global grey matter provides insight
into the overall responsiveness of the cerebrovasculature to the
breath-hold hypercapnia stimulus, it is critical that our analysis is
sensitive to regional variations in CVR within the brain in order to
identify threatened or damaged tissue areas in clinical patients. This
could be performed by averaging the BOLD signal within a region ofinterest, which has advantageous contrast- and signal-to-noise effects.
If the noise properties of the data are sufﬁcient, it may also be possible
to map CVR for every voxel in the brain; if the CVR accuracy is not
compromised, this method would provide the most insight for an ob-
serving clinician. To assess the limitations of measuring regional or
local CVR, three “scales of interest”were considered.
• Grey matter (GM)
The mean timeseries within the subject-speciﬁc GM mask was cal-
culated.
• Regions of interest (ROIs)
Regions were identiﬁed using the MNI atlas (Mazziotta et al., 2001)
and transformed into the individual subject functional data space:
frontal lobe, parietal lobe, temporal lobe, occipital lobe, insula, thala-
mus, and putamen. The transformed ROIs were then masked using
the subject-speciﬁc GM mask. The mean timeseries within these
ROIs were calculated.
• Voxels
Each voxel timeseries was considered independently.
The timing of BOLD response to respiratory challenges varies across
the healthy brain (Bright et al., 2009), and this temporalmismatchmust
be taken into account prior to further analysis. The breath-hold regres-
sors were shiftedwith respect to the data to account for delays between
the breath-hold challenge, the physiological response, and the resulting
BOLD signal changes. This delay was optimised using cross correlation
between the interpolated regressor and the appropriate timeseries
(GM, ROI, or voxel), shifted in steps of 0.1 s.
Cerebrovascular reactivity analysis
Cerebrovascular reactivity was measured using the framework of
a general linear model (GLM), where the beta-weight calculated for
the breath-hold regressor reﬂects the %BOLD signal change associated
with the hypercapnia challenges. When end-tidal CO2 regressors are
used, this value is quantiﬁed in units of %BOLD/mm Hg. A 3-degree
polynomial was also included to remove slow signal drift.
For each breath-hold scan, CVR was measured for the average
timeseries from within GM and within each ROI. The median values
of voxelwise CVR within the GM and ROI masks were calculated and
compared to assess the impact of the scale of analysis on CVR results.
Repeatability assessment
Toquantify the repeatability of our CVRmeasurements,we employed
the intra-class correlation coefﬁcient (ICC), which reﬂects the ratio be-
tween the data variance of interest (inter-subject CVR differences)
and the total data variance, including differences between the six
breath-hold scans. Under our assumption that the underlying vascular
Fig. 2. Schematic of analysis pipelines used in this study. Six breath-hold scans were ac-
quired to simulate varying levels of ability and consistency. Following standard data pre-
processing, CVR was calculated as follows: a breath-hold model was selected, a scale of
interest deﬁned, and an optimal delay time between breath-hold regressor and data de-
termined prior to including the regressor in a general linear model. CVR results obtained
using greymatter or ROI mean timeseries, as well as themedian CVR value obtained from
voxelwise values, were used to calculate the intraclass correlation coefﬁcient (ICC) across
the 12 subjects and 6 scans. The ICC quantiﬁes the repeatability of a subject's CVRmeasure
despite poor breath-hold performance. The voxelwise CVR values were also compared
within an individual subject dataset using correlation analysis and ICCspatial; both of
theseparameters assess the consistency of spatial patterns of voxelwise CVR valueswithin
the grey matter of one subject.
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sion, the ICC quantiﬁes whether the CVR value measured for a given
subject is repeatable across different breath-hold performances. Low
ICC values (near 0) indicate that CVRmeasurements vary greatly across
the six scans, relative to the variation between subjects. High ICC values
(near 1) indicate there is minimal variance across the six scans, relative
to inter-subject differences.
There are multiple forms of the ICC that are tailored to the speciﬁcs
of a given experiment; we apply the ICC(2,1), which considers the six
breath-hold scans to be a random sample of a larger population ofpossible breath-hold performances. This statistic therefore reﬂects a
broader range of breath-hold ability and consistency levels than that
which is simulated in the current study. The calculation of ICC(2,1) is
described in detail in the literature (Shrout and Fleiss, 1979). The ICC
values were also transformed into F-statistics to obtain the associated
p-values.
Firstly, we use the ICC to test the repeatability of our calculation
across the 12 subjects and 6 breath-hold scans using the All 20s Ramps,
Time-scaled Ramps, and End-tidal CO2 regressors. The CVR values mea-
sured using the GM or ROI timeseries, and the median voxelwise CVR
values within the GM or ROI masks, were compared.
Secondly, we use ICCspatial to measure whether the spatial distri-
bution of voxelwise CVR for an individual subject is reproducible
(Caceres et al., 2009; Raemaekers et al., 2007). This indicates whether
breath-hold challenges robustly map CVR heterogeneity across the
brain. The CVR values of individual voxels within a subject's GM mask
were compared across the six breath-hold datasets. The ICCspatial values
for the three breath-hold models were compared across subjects.
This spatial distribution repeatability was also assessed between
pairs of CVR maps: the All15 and Avg15 CVR maps (representing sim-
ilar ability but different consistency levels) All10 and All20 CVR maps
(representing different ability but similar consistency levels), and
Avg12.5 and Avg17.5 CVR maps (representing difference in both per-
formance factors) were compared by correlating the voxelwise CVR
values within the GM mask. Outlier voxels were identiﬁed as having
CVRvalues 3 standarddeviations above themeanGMvalue or displaying
negative CVR values (although physiologically possible, the interpreta-
tion of negative CVR values is outside the scope of this paper), and the
subject-speciﬁc GM masks were adjusted such that any voxels consid-
ered an outlier in any dataset were removed from analysis. The correla-
tion coefﬁcients were transformed into z(r) scores using the Fisher r–z
transform, and paired t-tests were used to determine signiﬁcant differ-
ences (p b 0.05, Bonferroni corrected for multiple comparisons).
Results
All subjects completed the six functional breath-hold scans. A
summary of the end-tidal CO2 effects related to the 6 breath-hold par-
adigms is shown in Fig. 3. The baseline end-tidal CO2 levels were sig-
niﬁcantly reduced in all six breath-hold scans relative to the resting
scan. This hypocapnia is likely related to the paced breathing; sub-
jects often breathe more deeply when consciously controlling their
respiration rate. Also, as expected, the breath-hold duration (perfor-
mance ability level) was coupled to the CO2 response: the end-tidal
CO2 range increased as the average breath-hold duration throughout
the scan was lengthened (e.g., from the All10s to the All20s datasets).
Fig. 3 contains the end-tidal CO2 regressors for each of the 6 scans
(group average, accounting for differing delay times across subjects).
CVR repeatability
The repeatability of the GMCVR values, obtained using the GMaver-
age timeseries, is illustrated in Fig. 4. The ICC values for the All 20s
Ramps, Time-scaled Ramps, and End-tidal CO2 analyses were 0.43, 0.45,
and 0.82, respectively. All values were signiﬁcant (p b 0.05). The ICC
was recalculated using the three scans with consistent performance
(All10, All15, All20) and the three with inconsistent performance
(Avg12.5, Avg15, Avg17.5), and the results are also provided in Fig. 4.
The correlation between the group mean CVR values and the group
mean range in end-tidal CO2 values across the six scans was assessed
to determine the presence of biases in the three breath-hold analysis
methods. CVR was signiﬁcantly correlated with the CO2 range in the
All 20s Ramps analysis (r = 0.92, p b 0.01). In contrast, the Time-scaled
Ramps analysis resulted in CVR values thatwere anticorrelatedwith the
end-tidal CO2 data, although this is not signiﬁcant (r = −0.75, p =
0.08). As by design, the End-tidal CO2 analysis was not signiﬁcantly
Fig. 3. Summary of the end-tidal CO2 effects associated with the six breath-hold scans. a) The baseline and range of end-tidal CO2 values for each subject are shown and the group
mean plotted (circles). The baseline end-tidal CO2 values were signiﬁcantly lower in all six breath-hold scans compared to the resting scan (*p b 0.0005, paired t-tests, Bonferroni
corrected for multiple comparisons). b) The group average end-tidal CO2 regressor for each of the six scans, accounting for temporal shifts between subjects.
563M.G. Bright, K. Murphy / NeuroImage 83 (2013) 559–568correlated with the CO2 data (r = 0.51, p = 0.30). Irrespective of
breath-hold model, the ICC values were higher in the data with greater
variability in the breath-hold performance.
The ICC values obtained from the mean timeseries (GM and ROIs)
and using the median voxelwise CVR value were compared (Fig. 5).
There was no signiﬁcant difference between the ICC values of the mean
timeseries and voxelwise methods. The use of end-tidal CO2 regressors
to calculate CVR resulted in higher ICC values than the All 20s Ramps or
Time-scaled Ramps analyses in all regions tested, for both the mean
timeseries and median voxelwise results (paired t-tests, all tests
p b 0.0001, Bonferroni corrected for multiple comparisons). The ICC re-
sults for the insula, thalamus, and putamen ROIs are similar to results in
larger ROIs (e.g., parietal, temporal lobes), suggesting that the size of
ROI does not dramatically limit the robustness of the CVRmeasurement
in this study.Spatial repeatability
The group results of the spatial correlation analysis between pairs
of CVR maps are shown in Fig. 6. The End-tidal CO2 analysis resulted in
signiﬁcantly higher z(r) scores than the Time-scaled Ramps analysis in
all three comparisons (the Avg12.5/Avg17.5 comparison was also sig-
niﬁcantly more correlated following End-tidal CO2 analysis than the
All 20s Ramps analysis). The Time-scaled Ramps analysis resulted in
signiﬁcantly lower z(r) scores than the All 20s Ramps analysis in two
of three comparisons. Examples of the CVR maps for one subject
(identiﬁed as having the median correlation values in the All15/
Avg15.0 comparisons) are provided in Fig. 7. The ICCspatial was calcu-
lated for each subject to test the reproducibility of CVR heterogeneity
across all six breath-hold scans: the results are presented in Table 1.ICCspatial was signiﬁcantly larger in the End-tidal CO2 analysis compared
to the All 20s Ramps model (p = 1 × 10−5) and Time-scaled Ramps
model (p = 4 × 10−5) (paired t-tests). Combined, these results show
that the End-tidal CO2 breath-hold model results in greater (and often
signiﬁcantly greater) repeatability of the voxelwise distribution of CVR
values across grey matter.Discussion
ICC and breath-hold modelling
We have simulated patient data (mimicking poor breath-hold
performance) in healthy volunteers to show that BOLD CVR can be
robustly mapped using breath-hold challenges, despite variation in
challenge ability and consistency. All breath-hold regressor types assessed
in this study resulted in signiﬁcant ICC values (F-test, p b 0.05) in analysis
of the GM timeseries. However, the results shown in Fig. 4 and the asso-
ciated correlation analysis suggest that there are systematic confounds
when using All 20s Ramps, and potentially the Time-scaled Ramps, to
model the breath-hold response. The All 20s Ramps analysis resulted
in CVR values correlated to the measured range in end-tidal CO2 of
each scan, indicating these regressors do not account for variation in
breath-hold ability (e.g., All10 or Avg12.5 data). This may lead to
“false-positives” in patient studies, in which abnormally low CVR values
may bemeasured due to difﬁculties performing the breath-hold task. In
contrast, the results of the Time-scaled Ramps analysis show a trend to-
wards anticorrelation with the end-tidal CO2 range. The CVR values
obtained using End-tidal CO2 regressors are, by design, the least corre-
lated with the end-tidal CO2 variance (and challenge ability) across
the six scans.
Fig. 4. Repeatability of CVR values obtained from theGMaverage timeseries across the six
breath-hold scans, for each of the 3 breath-holdmodels: All 20s Ramps, Time-scaled Ramps,
and End-tidal CO2 regressors. CVR values from individual subjects (thin lines) and the
group average (thick lines, circles) are shown. The ICC values were calculated from all
six breath-hold scans, the three consistent scans (All10, All15 and All20) and the three in-
consistent breath-hold scans (Avg12.5, Avg15.0 and Avg17.5) separately, and the results
are indicated on the graph.
Fig. 5. Repeatability of CVR values obtained for a region of interest. CVR was calculated
within grey matter (GM) voxels and within 7 additional regions of interest. Values were
calculated using both the GM or ROI mean timeseries and by calculating the median
voxelwise CVR value. The ICC across the six breath-hold scans was calculated for both
sets of results. ICC values below 0.4 (shaded grey) are considered to show “unacceptable”
repeatability for fMRI experiments. Across the 8 regions considered, the End-tidal CO2
analysis resulted in signiﬁcantly greater ICC values, using ROI or voxelwise CVR values,
compared to the All 20s Ramps and Time-scaled Ramps analyses (p b 0.0001, paired
t-tests, Bonferroni corrected for multiple comparisons).
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ceptable ICC for fMRI data. Although all of our ICC values reached sig-
niﬁcance (using CVR from the GM average timeseries), the End-tidal
CO2 regressors resulted in almost double the ICC of the other analysis
Fig. 6. Group results of correlation analysis between pairs of breath-holding datasets
that determine the effects of impaired consistency (All15/Avg15.0), impaired ability
(All10/All20), or both (Avg12.5/Avg17.5). Voxels within GM showed greater z(r) corre-
lation using the End-tidal CO2 regressors than using the Time-scaled Ramps regressors
in all comparisons. The All 20s Ramps model resulted in greater correlation than the
Time-scaled Ramps model in the All15/Avg15.0 and All10/All20 comparisons. The
End-tidal CO2 model showed greater correlation that the All 20s Ramps model in only the
Avg12.5/Avg17.5 comparison (*p b 0.05, paired t-tests, corrected for multiple comparisons).
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merous alternatives for reliability criteria in fMRI studies. Cicchetti and
colleagues have proposed ICC groupings of poor (b0.4), fair (0.41–0.59),
good (0.60–0.74) or excellent (N0.75) reliability (Cicchetti, 2001). This
stratiﬁcation has been adopted by more current fMRI research (van den
Bulk et al., 2012), noting that these thresholds parallel the suggested ac-
ceptance levels of the neuroimaging community of ICC N 0.4 (Aron et
al., 2006; Eaton et al., 2008). Under these guidelines, the All 20s Ramps
and Time-scaled Rampswould provide “acceptable” but only “fair” CVR re-
liability, while the End-tidal CO2 analysis provides “excellent” reliability.
When considering the three consistent (All10, All15, All20) and
three varied (Avg12.5, Avg15.0, Avg17.5) scans independently, the ICC
values for the GM timeseries were observed to be higher in the varied
breath-hold duration scans. This ﬁnding suggests that it may be prefer-
able to use breath-holding paradigms with varying challenge duration,
even in healthy volunteers, in order to improve the robustness of the
CVR measurement.
Finally, it is important to note that the End-tidal CO2model quantiﬁes
CVR measurements in units of %BOLD/mm Hg, rather than %BOLD. This
normalisation enables better comparison between CVR values obtained
in different sessions, or in different subjects, making cohort comparisons
and longitudinal studies more robust.
Regional CVR repeatability
The ROI analysis (Fig. 5) demonstrates that CVR can be reliably
measured in smaller brain regions in addition to all of grey matter.
The End-tidal CO2 model continued to achieve acceptable ICC values
(ranging from ICC = 0.45 in the occipital lobe mean timeseries to
0.86 in the parietal lobe using voxelwise analysis). The All 20s Ramps
and Time-scaled Ramps results often slipped from “fair” to unacceptable
ICC levels (ICC b 0.4).We conclude that regional CVR values require the
End-tidal CO2 model to achieve acceptable CVR repeatability.
To further understand the robustness of small scale CVR measure-
ments within an individual subject, we assessed the voxelwise corre-
lation between pairs of CVR maps and measured ICCspatial values
across all six CVR maps for each subject. The correlation analysis results
(shown in Fig. 6) indicate that the results of End-tidal CO2 analysis are sig-
niﬁcantly more repeatable between scans of different ability/consistency
than the Time-scaled Ramps results, and some of the All 20s Ramps results.
The ICCspatial analysis (Table 1) also demonstrates that the End-tidal CO2
model provides the most repeatable mapping of CVR variation within
the brain.CVR and breath-holding in clinical applications
As described earlier, a meta-analysis of CVR literature has demon-
strated a strong association between impaired CVR and stroke risk
(Gupta et al., 2012). Silvestrini et al. (2000) provide one example of
this connection, measuring correlation between CVR impairment and
the level of risk that a patient with severe stenosis will go on to experi-
ence an ischaemic event. As surgical interventions to open stenosed or
occluded vessels carry their own inherent risk of ischaemic events due
to the release of microemboli, CVR could help stratify patients and quan-
tify the relative risk and beneﬁts of surgery of each individual. In a pro-
spective study, Markus and Cullinane (2001) showed that severely
reduced cerebrovascular reactivity predicted the risk of ipsilateral stroke
and transient ischaemic attack (TIA) in patients with carotid occlusion
(and to a lesser extent in asymptomatic carotid stenosis). These two
examples used transcranial Doppler ultrasonography to measure CVR,
whereas whole-brain BOLD fMRI can better localise the downstream ef-
fects of arterial stenosis and provide even more powerful diagnostic in-
formation. For example, CO2 gas administration and BOLD CVR maps
determine the location and extent of abnormal vascular reactivity
secondary to proximal large-vessel stenoses, including steal phenome-
non, in moyamoya patients (Heyn et al., 2010; Mikulis et al., 2005).
Breath-holds have also been successfully used to measure BOLD CVR
in patientswith brain tumours; good agreementwith the results of gad-
olinium contrast administration was observed, and the authors suggest
that BOLDCVRmay bemore sensitive to certain types of vascular abnor-
malities than the DSC technique (Pillai and Zacá, 2011, 2012).
With these compelling arguments for acquiring BOLD CVRmaps in
a range of patient groups, why is it not routine clinical practice? The
difﬁculty in administering CO2 challenges and concerns regarding the
repeatability of CO2 paradigms may be responsible for the limited im-
plementation in clinical scenarios. Breath-hold paradigms have been
administered successfully to paediatric patients with moyamoya dis-
ease (Thomas et al., 2013), suggesting that even patient groups that
are notoriously difﬁcult to scan can successfully complete breath-hold
challenges in the MR scanning environment. The results presented in
the current study indicate that poor performance of breath-hold chal-
lenges is not necessarily a limiting factor in robust mapping of CVR in
patients; the End-tidal CO2 analysis method compensates for ability
and consistency factors and provides repeatable CVR values despite
these performance variations.
Considerations
Although the proposed breath-hold paradigm is relatively simple
compared to breathing circuits and gas delivery systems, it may still
cause problems for certain patient groups. For example, the use of a
nasal cannula to record end-tidal values would be of little use if a sub-
ject did not (or could not) breathe through their nose. Small modiﬁ-
cations to the experimental design (e.g., attaching the gas sampling
line to a face mask with minimal breathing resistance) could extend
the suitability of the breath-hold challenge without greatly impacting
the ease of use. However, there will always be patient groups that
lack the minimal compliance needed for a breath-hold challenge
(e.g., patients with dementia), and gas inhalation techniques may be
the only option for these individuals.
In addition, it is important to acknowledge that all respiratory
challenges can simultaneously alter oxygen levels in addition to CO2
levels: a breath-hold challenge results in mild hypoxia as well as the
intended hypercapnia. Although oxygen is vasoactive, there is minimal
impact on cerebral blood ﬂow within an end-tidal O2 range of 60–
150 mm Hg (Brugniaux et al., 2007). However, changes in arterial oxy-
gen can directly inﬂuence the BOLD contrast (Bulte et al., 2007). To as-
sess how oxygen is altered in our data, we assessed the baseline values
and ranges of end-tidal O2 data (results presented in the Supplemental
Figure), and compared the end-tidal O2 timeseries with the end-tidal
Table 1
Effect of CVR analysis method on the repeatability of the spatial distribution of voxelwise
CVR values. Using the voxelwise CVR maps, ICCspatial was calculated for each subject and
transformed into a z(r) statistic. The End-tidal CO2 analysis resulted in signiﬁcantly greater
z(r) values across the population relative to the All 20s Ramps (p = 1 × 10−5) and the
Time-scaled Ramps (p = 4 × 10−5) analyses.
Repeatability of CVR spatial distribution (ICCspatial)
Subject All 20s Ramps Time-scaled Ramps End-tidal CO2
1 0.87 1.10 1.13
2 0.69 0.63 1.02
3 0.95 1.02 1.26
4 0.73 0.60 0.87
5 0.66 0.78 1.00
6 0.78 0.85 1.02
7 0.91 0.93 1.07
8 0.71 0.78 0.89
9 0.78 0.55 0.93
10 0.79 0.71 0.97
11 1.00 0.60 1.07
12 1.05 0.66 1.10
mean 0.82 ± 0.13 0.77 ± 0.18 1.03 ± 0.11
Fig. 7. Example CVR maps for one subject. The All 20s Ramps and Time-scaled Ramps analysis result in CVR values with arbitrary units, whereas the End-tidal CO2 analysis results in
quantitative CVR values in units of %BOLD/mm Hg. All values within the modiﬁed grey matter mask are plotted for the All15 and Avg15.0 data, and the linear ﬁt (red line) and cor-
relation values indicated.
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atively correlated (r values ranging from−0.44 to−0.98; p b 0.1 × 10
−4; corrected for multiple comparisons). Thus, the effects of hypercap-
nia andhypoxia cannot be disentangled in our data. The extent of hypox-
ia associated with the breath-hold challenges (indicated by the range) is
enhanced with breath-hold duration, and could potentially cause an ar-
tifactual enhancement of BOLD CVR values. A recent study by Tancredi
and Hoge (2013), utilising a nearly identical breath-hold paradigm, ob-
served that the consequent mild hypoxia did not signiﬁcantly inﬂuence
the CVR results relative to gas inhalation methods that did not have a
hypoxic component. We therefore assert that the hypoxic component
of breath-hold challenges is not signiﬁcant in the current study. We en-
courage future studies to monitor both end-tidal O2 and end-tidal CO2
in order to determine whether transient hypoxia becomes critical in a
given patient group.
Finally, a recent study has demonstrated that the reactivity response
to CO2 is sigmoidal, and the baseline CO2 level determines whether the
reactivity response is in a linear or non-linear domain (Tancredi and
Hoge, 2013). As demonstrated in that study, and in Fig. 3, the paced
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compared to resting levels. This shift in baseline may thus impact our
reactivity measure. It is unlikely that this is a major factor in our data.
First, due to differences in paced breathing rates between the published
study and our own paradigm, we observe only −5 mm Hg changes
in baseline CO2 levels compared with −10 mm Hg hypocapnia
observed in the Tancredi and Hoge paper. Secondly, we have limited
our CVR analysis to relative changes in %BOLD signal; Tancredi and
Hoge observed signiﬁcant effects of baseline CO2 on absolute reac-
tivity measures but these were negligible when considering relative
measures. Finally, if the shift in baseline physiologymoved us into the
non-linear regime of a subject's dose–response curve, than we would
expect that end-tidal CO2 regressors describing breath-hold challenges
of varied effect sizes would no longer ﬁt the data robustly, reducing re-
peatability in group ICC analysis. The excellent ICC values achieved
using the End-tidal CO2 analysis method indicates that the inﬂuence of
a baseline shift in CO2 levels is not signiﬁcant in our study. However,
this may no longer hold true in patient groups with altered physiology
(Bright et al., 2010; Zhao et al., 2009). We recommend that the paced
breathing rate be targeted to match a patient's natural breathing rate
as closely as possible, to minimise the baseline hypocapnic effect.Conclusions
This study demonstrates that BOLD CVR can be mapped using
breath-holds, with high inter- and intra-subject repeatability, despite
variations in the duration and consistency of breath-hold performance.
High repeatability is achieved by incorporating end-tidal CO2 data into
the CVR analysis. Because end-tidal CO2 data represent the physiological
effects of the breath-hold challenge, regardless of how the challengewas
performed, any patient “misbehaviour” can be accounted for. We offer
the following guidelines for future work incorporating breath-holds
into studies of difﬁcult patient cohorts:
• End-tidal CO2 datamust be acquired and incorporated into CVR analysis
to account for variations in breath-hold performance (and inter-subject
differences in physiology) to achieve repeatable measures across the
brain.
• Patients can end breath-holds prematurely if needed; however, it is
important to stress that they brieﬂy exhale before resuming normal
breathing in order to obtain the most accurate end-tidal CO2 values
possible.
• An ideal breath-hold stimuluswould involve end-expiratory challenges
interleaved with periods of paced breathing. Details of the paradigm
can be adjusted to suit the target patient cohort (e.g. the paced breath-
ing could be manipulated to match the resting respiratory rate of the
subject, or auditory instructions could be supplied to subjects with
poor vision).
By incorporating end-tidal CO2 data into the acquisition and analysis
procedures, breath-hold challenges achieve robust CVR maps even in
“difﬁcult” subjects. These results support the use of breath-holding for
measuring CVR in clinical studies, and will hopefully encourage more
widespread implementation of this important diagnostic test.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.neuroimage.2013.07.007.Acknowledgments
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